LoHud | Ad Sales | Company

Morningstar® Investment Profileâ„¢

Â Â Â View: Â Â

Teva Pharmaceutical Industries, Ltd.Â Â TEVA

Data as of 11-20-2009 03:00 PM CT


Last Price	Day Change	Volume
$52.72	-0.32 (-0.60%)	3,998,745



Open Price	Day Range	52-Wk Range
$52.67	53.08 - 52.50	54.95 - 39.75



Mkt Cap($mil)	Yield	Avg Volume
48,081	0.92 %	4,688,539



P/E	P/S	P/CF
48.54	3.57	13.64

Â Stock Chart

Â Key Stats


Morningstar Style Box	Large Growth	Stock Type
Industry	Drug Manufacturers - Other	Sector	Health Care
Market CapÂ $Mil	48,081	SalesÂ $Mil	12,945

Â Company Profile

What Does This Company Do?

Established in 1901 as a drug wholesaler, Teva Pharmaceutical has become the world's largest generic drug company. Based in Israel, Teva develops, manufactures, and commercializes generic and branded drugs. It supplies raw materials to competitors through its bulk pharmaceutical business. On the branded side, Teva produces Copaxone, a multiple sclerosis therapy with annual sales of around $1.7 billion, although only a portion of this amount is recognized as revenue to Teva.

Address	5 Basel St.
Â	P.O. Box 3190
Â	Petach Tikva,Â IS,Â 49131
Phone	972 39267267
Website	http://www.tevapharm.com
Employees	38,307
Direct Investment		Yes
Dividend Reinvestment		Yes

Quotes for Nasdaq securities are delayed 15 minutes. Quotes for NYSE and Amex securities are delayed 20 minutes, and are supplied by www.sdsmarketwatch.com. Graph Times are Eastern Standard. Copyright© 2008.

Show Data Definitions